Physician profile
Mark R Ranzinger
NPI 1457339111
$20,535.16
in general payments reported to CMS, 2019-2025
16 companies · $4,384 in 2025
The $4,384 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,250 · 2020: $40.66 · 2021: $161 · 2022: $4,148 · 2023: $1,803 · 2024: $7,748 · 2025: $4,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,790 · Education: $4,098 · Food and Beverage: $2,647 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,789.59 |
| Education | $4,098.00 |
| Food and Beverage | $2,647.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,309.65 | 2024-2025 | |
| Davol INC. | $4,933.82 | 2019-2025 | Phasix Mesh |
| Arthrex, INC. | $2,424.00 | 2022 | |
| Medical Device Business Services, INC. | $1,677.01 | 2023-2024 | Enseal, Linx Reflux Management System |
| Crossroads Orthopedics, LLC | $851.69 | 2022 | |
| Ethicon INC. | $800.00 | 2019 | |
| Senseonics, Incorporated | $400.00 | 2025 | Eversense |
| Ethicon US, LLC | $397.48 | 2019-2025 | Linx Reflux Management System, Echelon; Endopath, Stratafix |
| E.R. Squibb & Sons, L.L.C. | $382.82 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $150.16 | 2019 | |
| Kerecis Limited | $103.20 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Regeneron Healthcare Solutions, INC. | $29.12 | 2023 | Libtayo |
| Organogenesis INC. | $27.65 | 2023 | Puraply |
| Merck Sharp & Dohme LLC | $18.54 | 2025 | Keytruda |
| Avanos Medical | $17.09 | 2025 | On-Q Pump and Accessories |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ranzinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.